Pharmaceutical Technology
FEBRUARY 27, 2025
Pfizer has ended the global commercialisation of its haemophilia B (factor IX deficiency) gene therapy Beqvez, citing soft demand for gene therapies among haemophilia patients and physicians.
MedCity News
FEBRUARY 28, 2025
To bridge the gap between invasive and non-invasive technologies, nanoscale materials, such as biocompatible nanoparticles, provide a promising alternative, allowing us to design materials at the scale of cellular systems and structures. The post Biocompatible Nanoparticles: Tiny Antennae with Huge Potential for Brain-Computer Interfaces appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
FEBRUARY 24, 2025
Health agency job cuts and a newly-established MAHA commission leave many unanswered questions about potential reforms and impact on drug approvals.
European Pharmaceutical Review
FEBRUARY 26, 2025
A study has demonstrated a new approach to prepare tablets for intestinal drug delivery by combining two 3D printing techniques. Using both selective laser sintering (SLS) and fused deposition modelling (FDM), the technique has potential to achieve delayed and prolonged drug release, according to the findings. Key findings from the 3D printing drug delivery study [a] laser speed of 90 mm s1 was suitable for producing [3D printed tablet] cores with relatively short disintegration time and suffici
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
Eversana Intouch
FEBRUARY 28, 2025
In the ever-evolving landscape of pharmaceutical marketing, staying ahead of the curve is crucial. Ann Cave, president of full-service agencies at EVERSANA INTOUCH, shares invaluable insights in her article, “How Harnessing Creativity, Data and Innovation Can Help Make a Difference in a Rare Disease Patients Journey,” published in Med Ad News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmaVoice
FEBRUARY 27, 2025
Recursion CFO Ben Taylor discusses the state of AI M&A and what companies should look for as the industry moves to new data technologies and systems.
Healthcare Success
FEBRUARY 24, 2025
This week's podcast dives into successful sales leadership and is relevant to most healthcare verticals, including B2B sales in SaaS, pharmaceuticals, medical device, hospitals, etc. It also applies to high-value B2C sales, e.g., elective surgeries, orthodontics, senior care, and residential treatment centers. My guest, Chris Jennings , CEO of Chris Jennings Group , reveals the essential traits of successful healthcare sales leadership.
Eversana Intouch
FEBRUARY 28, 2025
In recent years, notable progress has been made to highlight the vast gap in womens health and boost awareness around it. On average, women spend 25% more of their lives in poor health compared to men, and closing this gap could add at least $1 trillion to annual global GDP by 2040. Fortunately, more publications and studies are also emerging to point out under-researched and under-diagnosed women-specific conditions (such as endometriosis and menopause) and conditions that disproportionally aff
MedCity News
FEBRUARY 26, 2025
Eikon Therapeutics lead drug candidate is designed to activate toll-like receptors 7 and 8, sparking an immune response that fights cancer. Beyond this TLR7/8 agonist, the biotech is also developing PARP inhibitors that could have advantages over cancer drugs currently available from this class. The post Eikon Raises $350M for Cancer Drug Pipeline Led by Melanoma Med in Pivotal Testing appeared first on MedCity News.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
PharmaVoice
FEBRUARY 26, 2025
The number of candidates in development has nearly doubled over the past 15 years.
Referral MD
FEBRUARY 28, 2025
We live in a world of instant communication and on-demand services. Yet, the healthcare experience often begins with a decidedly analog ritual: The dreaded patient intake form. While medical science advances, too many clinics still rely on cumbersome paperwork. For too long, the administrative side of healthcare has lagged behind its clinical advancements.
Pharma Marketing Network
FEBRUARY 27, 2025
Introduction In todays fast-paced world, pharma digital marketing is more than just a strategyit’s a necessity. With increasing competition, strict regulations, and changing consumer behavior, pharmaceutical brands must embrace digital transformation to stay relevant. But how can pharma marketers break through the noise, engage their audience, and see real ROI?
MedCity News
FEBRUARY 28, 2025
The way ahead for HEOR in biopharma should be built on increasing C-suite visibility and understanding of the value contribution that HEOR makes and demonstrating that a failure to invest in HEOR puts companies at a competitive disadvantage, especially in the face of rising regulatory and payer expectations for evidence. The post Health Economics and Outcomes Research: Biopharmas Underappreciated Value Creator appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
PharmaVoice
FEBRUARY 28, 2025
The company is leaning on its subcutaneous technology to deliver long-acting options that could prevent patients from cycling through drugs.
Scott Burrows
FEBRUARY 28, 2025
In business, leadership, and life, theres a reason the windshield is bigger than the rearview mirroryour focus should always be on where youre going, not just where youve been. But that doesnt mean the past is irrelevant. In fact, the rearview mirror serves a critical purpose: it helps us learn, adjust, and make better decisions moving forward. The key is knowing how to glance back without getting stuck there.
European Pharmaceutical Review
FEBRUARY 25, 2025
Scientists have developed a new, potentially safer method to produce ethylene oxide. Based on the proposed technique, adding small amounts of nickel atoms to silver catalysts can maintain production efficiency while eliminating the need for chlorine, leading to a reduced environmental impact for ethylene oxide manufacturing. What sparked this development?
MedCity News
FEBRUARY 28, 2025
Womens cardiovascular risk factors often don’t get the attention they merit until it’s too late. Systole Health CEO and Co-founder talked about how the company addresses this challenge. The post A Startup Provides Physician-led Virtual Visitsfor Women at Risk for Heart Disease appeared first on MedCity News.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
FEBRUARY 25, 2025
Ten out of 11 children with congenital deafness treated with a gene therapy developed by Regeneron have seen "notable" improvements in hearing
Pharma IQ
FEBRUARY 26, 2025
Discover how AI is transforming pharmaceutical development, from drug discovery to clinical trials, supply chain resilience, and personalised medicine.
European Pharmaceutical Review
FEBRUARY 24, 2025
The UKs National Institute For Health And Care Excellence (NICE) has recommended an innovative combination immunotherapy for use on the NHS. The therapy is indicated for individuals with the blood cancer called acute lymphoblastic leukaemia (ALL). As a bispecific T-cell engager (BiTE) therapy, Blincyto (blinatumomab) provides a new treatment approach, helping the immune system to recognise and eliminate residual cancer cells following initial treatment.
MedCity News
FEBRUARY 28, 2025
Through a partnership with Nourish, Tias members will have access to virtual personalized nutrition guidance that can address a range of needs, such as hormonal balance, fertility, chronic disease management and weight management. The post Tia Teams Up with Nourish to Provide Nutrition Support to Women appeared first on MedCity News.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
PharmaVoice
FEBRUARY 25, 2025
Terns Pharmaceuticals sees blockbuster promise for two potential best-in-class molecules in obesity and oncology.
PharmaTimes
FEBRUARY 26, 2025
Updated data from phase 2 study reveals survival benefit
pharmaphorum
FEBRUARY 27, 2025
An FDA advisory committee due to be held in March to discuss the formulation of influenza vaccines for the 2025/26 flu season has been cancelled.
MedCity News
FEBRUARY 25, 2025
Thermo Fisher Scientific agreed to acquire the Purification and Filtration business of 3M spinoff Solventum. Filters and membranes from this business segment are used globally in applications such as biopharmaceutical manufacturing. The post Thermo Fisher Beefs Up in Bioprocessing With $4B Acquisition of Solventum Biz Segment appeared first on MedCity News.
Advertiser: ZoomInfo
In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.
PharmaVoice
FEBRUARY 25, 2025
Cavazzoni stepped down from her role as head of the FDA’s main drug review office in mid-January. She will succeed Aida Habtezion.
Pharmaceutical Technology
FEBRUARY 24, 2025
With Novo Nordisks blockbuster drugs Wegovy and Ozempic back in stock, copycat versions are no longer allowed for now.
pharmaphorum
FEBRUARY 25, 2025
In a move that will raise eyebrows in Washington, Pfizer has hired former FDA director Patricia Cavazzoni as its new chief medical officer
Expert insights. Personalized for you.
66 
Let's personalize your content